Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Sep 01, 2011 7:35pm
249 Views
Post# 19004923

RE: RE: RE: @cacheinvestor

RE: RE: RE: @cacheinvestorSo, ummm, let's do a little math, vikink. I figured you'd have done this already but I guess not. You can do this in your head, Vikink, at least the rest of us can.
.
Let's say, worst case, that we'll see 50% dilution from this point, hard to imagine that, but let's just say. And let's be conservative and assume the final price of this on success will be $30.00 without dilution, a third less or $20 with dilution from here at 50% more than outstanding today.
.
So, on shares bought today at $1.50, we'll see $20.00/$1.50 or a 13.3 bagger!
.
Now, I'm going to spend the evening looking at this so I can figure out why you say that would be a loss!!!
.
roflmao
.
How old are you? 15, maybe?
.
Bullboard Posts